Flexus Biosciences is a biotechnology company focused on the discovery, development, and commercialization of novel anti-cancer therapeutics, leveraging insights in immunology to develop Agents for Reversal of Tumor Immunosuppression (ARTIS)
Flexus Biosciences is a biotechnology company focused on the discovery, development, and commercialization of novel anti-cancer therapeutics, leveraging insights in immunology to develop Agents for Reversal of Tumor Immunosuppression (ARTIS).